MAPT and Alzheimer disease: In summary, it seems possible that the positive effects of VEGF-like compounds observed in AD models are associated with an improved drainage capacity of the BLS, which only becomes clinically evident in advanced stages of AD, when tau and amyloid accumulation overcomes neuronal plasticity and BLS clearance.